Overview of Dr. Riaz
Dr. Nadeem Riaz is a radiation oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Stanford University School of Medicine and has been in practice 8 years. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2010 - 2014
Stanford University School of MedicineClass of 2009
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2010 - 2026- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy.Victor Ng, Sonali Sinha, Ardijana Novaj, Jennifer Ma, Niamh McDermott
Clinical Cancer Research. 2024-12-16 - 2 citationsAn Analysis of Positron Emission Tomography Maximum Standard Uptake Value Among Patients With Head and Neck Cancer Receiving Photon and Proton Radiation.Irini Youssef, Nader Mohamed, Daniel Kallini, Kaveh Zakeri, Haibo Lin
International Journal of Radiation Oncology, Biology, Physics. 2024-12-01 - Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab.Tyler J Alban, Nadeem Riaz, Prerana Parthasarathy, Vladimir Makarov, Sviatoslav Kendall
Nature Medicine. 2024-11-01
Journal Articles
- The Importance of Locoregional Therapy in Metastatic Nasopharyngeal CancerNadeem Riaz, MD, JAMA Oncology
- Multi-Dimensional Genomic Analysis of Myoepithelial Carcinoma Identifies Prevalent Oncogenic Gene FusionsIan Ganly, Alan L Ho, Ronald Ghossein, Nadeem Riaz, Cristina R Antonescu, Nora Katabi, Nature
Authored Content
- The Importance of Locoregional Therapy in Metastatic Nasopharyngeal CancerJuly 2020
Press Mentions
New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck CancerJanuary 20th, 2022- For People with Certain BRCA Mutations, Activating the Immune System Could Be Promising TreatmentDecember 1st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
